Evidence map›Paper›PMID 38214710›Full record

Trial reportEuropean journal of nutrition2024

Shatavari supplementation in postmenopausal women alters the skeletal muscle proteome and pathways involved in training adaptation.

Mary F O'Leary, Sarah R Jackman, Joanna L Bowtell

Registry-linked trialOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in European journal of nutrition, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05025917 (Assessing the Effect of Shatavari Supplementation on Bone and Skeletal Muscle Health in Healthy Postmenopausal Women), which is not on this map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05025917 nacompletednot on this map

Assessing the Effect of Shatavari Supplementation on Bone and Skeletal Muscle Health in Healthy Postmenopausal Women: A Randomised Double Blind Clinical Trial

TypeinterventionalSponsorUniversity of ExeterRan2019 to 2020Enrolled24ConditionsMuscle Weakness, Osteoporosis, PostmenopausalArmsShatavari, Magnesium stearate
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. SheVari4Food & nutrition research · 2026
    Article
  6. Review
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Mary F O'LearyDepartment of Public Health and Sport Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK. m.oleary@exeter.ac.uk.ORCID http://orcid.org/0000-0003-1845-9568
Sarah R JackmanDepartment of Public Health and Sport Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK.ORCID http://orcid.org/0000-0003-2928-8266
Joanna L BowtellDepartment of Public Health and Sport Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK.ORCID http://orcid.org/0000-0002-4281-9212
University of Exeter · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeShatavari is an understudied, widely available herbal supplement. It contains steroidal saponins and phytoestrogens. We previously showed that six weeks of shatavari supplementation improved handgrip strength and increased markers of myosin contractile function. Mechanistic insights into shatavari's actions are limited. Therefore, we performed proteomics on vastus lateralis (VL) samples that remained from our original study.

methodsIn a randomised double-blind trial, women (68.5 ± 6 years) ingested either placebo or shatavari (equivalent to 26,500 mg/d fresh weight) for six weeks. Tandem mass tag global proteomic analysis of VL samples was conducted (N = 7 shatavari, N = 5 placebo). Data were normalized to total peptides and scaled using a reference sample. Data were filtered using a 5% FDR. For each protein, the pre to post supplementation difference was expressed as log2 fold change. Welch's t tests with Benjamini-Hochberg corrections were performed for each protein. Pathway enrichment (PADOG, CAMERA) was interrogated in Reactome (v85).

resultsNo individual protein was significantly different between supplementation conditions. Both PADOG and CAMERA indicated that pathways related to (1) Integrin/MAPK signalling, (2) metabolism/insulin secretion; (3) cell proliferation/senescence/DNA repair/cell death; (4) haemostasis/platelets/fibrin; (5) signal transduction; (6) neutrophil degranulation and (7) chemical synapse function were significantly upregulated. CAMERA indicated pathways related to translation/amino acid metabolism, viral infection, and muscle contraction were downregulated.

conclusionOur analyses indicate that shatavari may support muscle adaptation responses to exercise. These data provide useful signposts for future investigation of shatavari's utility in conserving and enhancing musculoskeletal function in older age.

trial registrationNCT05025917 30/08/21, retrospectively registered.

Indexed as

ProteomeResistance TrainingDietary SupplementsDouble-Blind MethodFemaleHand StrengthHumansMuscle, SkeletalMuscle StrengthPostmenopauseProteomicsProteomeAsparagus racemosusNutritionProteomicsSkeletal muscle

Identifiers

PMID38214710
PMCPMC10948523
OpenAlexW4390796039

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.